Proxy advisor ISS backs Bristol-Myers takeover of Celgene
Proxy advisory firm Institutional Shareholder Services on Friday recommended that shareholders of drugmaker Bristol-Myers Squibb Co vote in favor of its proposed $74 billion takeover of rival Celgene...
Read More